bendroflumethiazide has been researched along with Coronary Disease in 19 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the effect of baseline heart rate on the efficacy of atenolol-based compared with amlodipine-based therapy in patients with hypertension uncomplicated by coronary heart disease in the ASCOT-BPLA (Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm)." | 5.14 | Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial). ( Campbell, NR; Dahlöf, B; Dobson, JE; Poulter, NR; Sever, PS; Wedel, H, 2009) |
| "Treatment with propranolol in non-smoking men in the highest age and blood pressure categories would lead to a reduction in the number having strokes from three to one or two and might possibly reduce the number experiencing myocardial infarction from seven to four." | 2.66 | Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party. ( , 1988) |
| "Hypertension is an important risk factor for adverse cardiovascular events including stroke, myocardial infarction, heart failure and renal failure." | 2.55 | Pharmacotherapy for hypertension in adults aged 18 to 59 years. ( Gueyffier, F; Musini, VM; Puil, L; Salzwedel, DM; Wright, JM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (73.68) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musini, VM | 1 |
| Gueyffier, F | 1 |
| Puil, L | 1 |
| Salzwedel, DM | 1 |
| Wright, JM | 1 |
| Poulter, NR | 1 |
| Dobson, JE | 1 |
| Sever, PS | 1 |
| Dahlöf, B | 1 |
| Wedel, H | 1 |
| Campbell, NR | 1 |
| JOHNSTON, LC | 1 |
| GRIEBLE, HG | 1 |
| SCHOENBERGER, JA | 1 |
| FULLER, JB | 1 |
| Füessl, HS | 1 |
| Rahn, KH | 1 |
| Cressman, MD | 1 |
| Gifford, RW | 1 |
| Christiansen, C | 2 |
| Christensen, MS | 2 |
| Hagen, C | 2 |
| Stocklund, KE | 2 |
| Transbøl, I | 2 |
| Jensen, J | 1 |
| Miall, WE | 3 |
| Sigurd, B | 1 |
| Olesen, KH | 1 |
| Wennevold, A | 1 |
| Greenberg, G | 1 |
| Brennan, P | 1 |
| Dollery, C | 1 |
| Brennan, PJ | 1 |
| Breckenridge, A | 1 |
| Hentzer, L | 1 |
| Persson, I | 1 |
2 reviews available for bendroflumethiazide and Coronary Disease
| Article | Year |
|---|---|
Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Cause of Death; Coronary Diseas | 2017 |
Beta-blockers vs. thiazides in the treatment of hypertension: a review of the experience of the large national trials.
Topics: Adrenergic beta-Antagonists; Bendroflumethiazide; Clinical Trials as Topic; Coronary Disease; Diuret | 1990 |
10 trials available for bendroflumethiazide and Coronary Disease
| Article | Year |
|---|---|
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Europe; | 2009 |
Controversies in hypertension: mild hypertension, isolated systolic hypertension, and the choice of a step one drug.
Topics: Adult; Aged; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; | 1983 |
[Effects of natural estrogen/gestagen and thiazide on cardiovascular risk factors in normal menopausal women. A 2-year double-blind placebo study].
Topics: Adult; Bendroflumethiazide; Coronary Disease; Double-Blind Method; Estrogens; Female; Humans; Menopa | 1981 |
The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
Topics: Adult; Bendroflumethiazide; Benzoates; Butylamines; Chlorides; Clinical Trials as Topic; Coronary Di | 1975 |
MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Cerebrovascular Disorders; Clinical Trials as Topic; Cor | 1985 |
Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Medical Research Council Working Party on Mild Hypertension.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Human | 1988 |
The mild hypertension dilemma: results of the British MRC trial.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Cardiovascular Diseases; Cerebrovascular Disord | 1986 |
Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party.
Topics: Adult; Age Factors; Bendroflumethiazide; Blood Pressure; Cerebrovascular Disorders; Coronary Disease | 1988 |
Further results of the MRC treatment trial for mild hypertension.
Topics: Bendroflumethiazide; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Death, S | 1987 |
The Medical Research Council Hypertension Trial: the smoking patient.
Topics: Adult; Bendroflumethiazide; Cerebrovascular Disorders; Coronary Disease; Female; Humans; Hypertensio | 1988 |
7 other studies available for bendroflumethiazide and Coronary Disease
| Article | Year |
|---|---|
TREATMENT OF ARTERIAL HYPERTENSIVE DISEASE WITH DIURETICS. III. CHLORTHALIDONE ALONE AND IN COMBINATION WITH SPIRONOLACTONE.
Topics: Bendroflumethiazide; Cardiomegaly; Chlorides; Chlorthalidone; Coronary Disease; Creatine; Creatinine | 1964 |
[Antihypertensive therapy: campaign of the giants].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; D | 2005 |
[Treating essential hypertension. Are beta blockers still first choice?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Cor | 2007 |
Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study.
Topics: Adult; Bendroflumethiazide; Blood Glucose; Blood Pressure; Body Weight; Coronary Disease; Double-Bli | 1981 |
Treating mild hypertension.
Topics: Bendroflumethiazide; Cerebrovascular Disorders; Coronary Disease; Female; Humans; Hypertension; Male | 1985 |
Hypertension. I.
Topics: Adult; Bendroflumethiazide; Cerebrovascular Disorders; Coronary Disease; Diuretics; Female; Humans; | 1971 |
Small bowel ulceration. An evaluation of thiazide therapy.
Topics: Aged; Bendroflumethiazide; Biphenyl Compounds; Burns, Chemical; Coronary Disease; Delayed-Action Pre | 1968 |